Amylyx Pharmaceuticals, Inc. AMLX Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Amylyx Pharmaceuticals, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s cash ratio?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported cash ratio of 14.4× in Q1 2026.
- How has Amylyx Pharmaceuticals, Inc.'s cash ratio changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s cash ratio increased by 330.6% year-over-year, from 3.3× to 14.4×.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s cash ratio?
- Over 4 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s cash ratio has grown at a 36.4% compound annual growth rate (CAGR), from 2.9× to 10×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.